Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
37
37 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- HSK44459Phase 39 trials
Haisco Pharmaceutical Group Co., Ltd. · Psoriasis, Idiopathic Pulmonary Fibrosis (IPF), Progressive Pulmonary Fibrosis
- Inhaled TreprostinilLIQ861 Inhaled Treprostinil, Inhaled prostacyclinPhase 35 trials
United Therapeutics · Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
- BMS-986278AdmilparantPhase 33 trials
Bristol Myers Squibb · Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis
- HEC585Phase 33 trials
Sunshine Lake Pharma Co., Ltd. · Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF), Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)
- BI 1015550Phase 32 trials
Boehringer Ingelheim · Lung Diseases, Interstitial, Idiopathic Pulmonary Fibrosis
- DeupirfenidonePhase 32 trials
PureTech · Idiopathic Pulmonary Fibrosis (IPF), Idiopathic Pulmonary Fibrosis
- INS018_055Phase 32 trials
InSilico Medicine Hong Kong Limited · Idiopathic Pulmonary Fibrosis (IPF), Idiopathic Pulmonary Fibrosis
- REGEND001Phase 32 trials
Regend Therapeutics · COPD (Chronic Obstructive Pulmonary Disease), Idiopathic Pulmonary Fibrosis
- TDI01Phase 32 trials
Beijing Tide Pharmaceutical Co., Ltd · GVHD, Chronic, Idiopathic Pulmonary Fibrosis (IPF)
- AK3280Phase 31 trial
Shanghai Ark Biopharmaceutical Co., Ltd. · Idiopathic Pulmonary Fibrosis (IPF)
- SC1011Phase 31 trial
Guangzhou JOYO Pharma Co., Ltd · Idiopathic Pulmonary Fibrosis
- HB0056Phase 22 trials
Shanghai Huaota Biopharmaceutical Co., Ltd. · Asthma, Idiopathic Pulmonary Fibrosis (IPF)
- IfetrobanPhase 22 trials
Cumberland Pharmaceuticals · Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited
- TTI-101Phase 22 trials
Tvardi Therapeutics, Incorporated · Hepatocellular Carcinoma, Idiopathic Pulmonary Fibrosis
- ABBV-142Phase 21 trial
AbbVie · Idiopathic Pulmonary Fibrosis
- AGMB-447Phase 21 trial
Agomab Spain S.L.U. · Idiopathic Pulmonary Fibrosis (IPF)
- AP02Phase 21 trial
Avalyn Pharma Inc. · Idiopathic Pulmonary Fibrosis (IPF)
- AZD8965Phase 21 trial
AstraZeneca · Idiopathic Pulmonary Fibrosis (IPF)
- BBT-877Phase 21 trial
Bridge Biotherapeutics, Inc. · Idiopathic Pulmonary Fibrosis
- BC006Phase 21 trial
Dragonboat Biopharmaceutical Company Limited · Idiopathic Pulmonary Fibrosis (IPF)
- BI 1819479Phase 21 trial
Boehringer Ingelheim · Idiopathic Pulmonary Fibrosis
- BI 3810477Phase 21 trial
Boehringer Ingelheim · Idiopathic Pulmonary Fibrosis
- BI 765423Phase 21 trial
Boehringer Ingelheim · Idiopathic Pulmonary Fibrosis
- CAL101Phase 21 trial
Calluna Pharma AS · Idiopathic Pulmonary Fibrosis
- CHF10067Phase 21 trial
Chiesi Farmaceutici S.p.A. · Idiopathic Pulmonary Fibrosis
- DWN12088DWN12088 XmgPhase 21 trial
Daewoong Pharmaceutical Co. LTD. · Idiopathic Pulmonary Fibrosis
- ENV-101taladegibPhase 21 trial
Endeavor Biomedicines, Inc. · Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease
- HSK50042Phase 21 trial
Haisco Pharmaceutical Group Co., Ltd. · Idiopathic Pulmonary Fibrosis (IPF)
- LTI-03Phase 21 trial
Rein Therapeutics · Idiopathic Pulmonary Fibrosis (IPF)
- MTX-463Phase 21 trial
Mediar Therapeutics · Idiopathic Pulmonary Fibrosis
- ND-003Phase 21 trial
Shenzhen NewDEL Biotech, Co., Ltd · Idiopathic Pulmonary Fibrosis (IPF)
- ORJ-001Phase 21 trial
Oorja Bio, Inc. · Idiopathic Pulmonary Fibrosis
- PIPE-791Phase 21 trial
Contineum Therapeutics · Idiopathic Pulmonary Fibrosis
- SB17170Phase 21 trial
SPARK Biopharma · IPF, Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)
- SV001Phase 21 trial
Shanghai Synvida Biotechnology Co.,Ltd. · Idiopathic Pulmonary Fibrosis(IPF)
- SYH2059Phase 21 trial
InnovStone Therapeutics Limited · Idiopathic Pulmonary Fibrosis
- SYH9061Phase 21 trial
CSPC-NBP Pharmaceutical Co., Ltd. · Idiopathic Pulmonary Fibrosis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.